Home The Word Brain	My Amedeo FAQ Privacy About
	Hanzi Hunter Learning 500 Chinese characters in 30 days is possible. Abstract • About

Dyslipidemia

Free Subscription 23.03.2026 1 Am J Cardiol 6 Atherosclerosis 1 Diabetes 2 J Clin Endocrinol Metab 3 PLoS One

Retrieve available abstracts of this week’s articles: HTML format

Single Articles

Am J Cardiol

1. CHRISTENSEN E, Hillenbrand C, Kutty A, Jiang X, et al
   A Systematic Review and Meta-Analysis of Breast Arterial Calcification and Its Association with Cardiovascular Disease and All-Cause Mortality.
   Am J Cardiol. 2026 Feb 3:S0002-9149(26)00038.
   PubMed         Abstract available
   
   

   
   Atherosclerosis

2. VAN DEN BOSCH SE, Kowsoleea FC, Corpeleijn WE, Huisman SA, et al
   Statin-associated symptoms and statin intolerance in children with familial hypercholesterolemia: Insights from 15 years of clinical practice.
   Atherosclerosis. 2026;414:120659.
   PubMed         Abstract available
   
   
3. ARIF A, Karungi I, Stevens CAT, Elshorbagy A, et al
   Attainment of non-high-density lipoprotein cholesterol targets in secondary and primary care: A secondary-analysis of the DA VINCI study.
   Atherosclerosis. 2026;414:120644.
   PubMed         Abstract available
   
   
4. MANSFIELD BS, Bene-Alhasan Y, Ballantyne CM, Raal FJ, et al
   The evolving therapeutic landscape of PCSK9 inhibition.
   Atherosclerosis. 2026;414:120670.
   PubMed         Abstract available
   
   
5. RAAL FJ, Greber-Platzer S, Reeskamp LF, Iannuzzo G, et al
   Efficacy of evinacumab by genotype and low-density lipoprotein receptor function in patients with homozygous familial hypercholesterolaemia: A subanalysis from the ELIPSE open-label extension study.
   Atherosclerosis. 2026;414:120657.
   PubMed         Abstract available
   
   
6. MANCINI GBJ, Ryomoto A, Ruel I, Iatan I, et al
   Assessment of LDL receptor-dependent lipid lowering therapies in patients with homozygous familial hypercholesterolemia according to functional genotype.
   Atherosclerosis. 2026;414:120646.
   PubMed         Abstract available
   
   
7. TOKGOZOGLU L, Kayikcioglu M, Roeters van Lennep J
   Sex-specific differences in cardiovascular risk factors and their management.
   Atherosclerosis. 2026;414:120641.
   PubMed         Abstract available
   
   

   
   Diabetes

8. XIE C, White JB, Huang W, Horowitz M, et al
   Endogenous Glucagon-Like Peptide 1 Enhanced by Vildagliptin Reduces Triglyceride Appearance During Intraduodenal Fat Infusion in Type 2 Diabetes.
   Diabetes. 2026 Jan 27:db250980. doi: 10.2337/db25-0980.
   PubMed         Abstract available
   
   

   
   J Clin Endocrinol Metab

9. SALVIO G, Ciarloni A, Aboud N, Ambo N, et al
   The effect of hypercortisolism treatment on dyslipidemia in Cushing syndrome: systematic review and meta-analysis.
   J Clin Endocrinol Metab. 2026;111:1187-1202.
   PubMed         Abstract available
   
   
10. KVERNEBO SUNNERGREN K, Norup PB, Haahr ME, Giraldi A, et al
    Effects of Puberty Suppression and Sex Steroids on Weight, BMI, and Lipid Profiles in Danish Transgender Adolescents.
    J Clin Endocrinol Metab. 2026;111:1066-1074.
    PubMed         Abstract available
    
    

    
    PLoS One

11. CHECKOLE N, Cheneke W, Ibrahim T, Bekele S, et al
    Malaria parasitemia and its association with liver function parameters, and lipid profile among malaria-infected adult patients in western Ethiopia: A comparative cross-sectional study.
    PLoS One. 2026;21:e0345059.
    PubMed         Abstract available
    
    
12. TOLLA KS, Solela G, Wondafrash G, Burusie A, et al
    Incidence and risk factors of calcium channel blocker-related edema in hypertensive patients: A Multicenter retrospective cohort study.
    PLoS One. 2026;21:e0336659.
    PubMed         Abstract available
    
    
13. DE FRANCA AS, Saldanha AS, da Silva AM, Pirkle CM, et al
    Associations of cardiovascular risk factors with handgrip strength and gait speed among older males and females: A systematic review protocol.
    PLoS One. 2026;21:e0344309.
    PubMed         Abstract available
    
    

Thank you for your interest in scientific medicine.

AMEDEO Dyslipidemia is free of charge. Privacy / Datenschutzerklärung | Imprint / Impressum